Press release
Anti-Inflammatory Therapeutics Market to Reach USD 152.7 Billion by 2034
Anti-Inflammatory Therapeutics Market
Download Full PDF Sample Copy of Market Report @
https://exactitudeconsultancy.com/request-sample/49921
Introduction
The global Anti-Inflammatory Therapeutics Market is experiencing powerful growth as chronic inflammatory diseases become increasingly common worldwide. With autoimmune disorders, musculoskeletal conditions, and respiratory inflammations on the rise, demand for effective therapies-including NSAIDs, corticosteroids, biologics, and advanced targeted immunomodulators-continues to surge. This press release highlights the major market shifts, emerging innovations, and forecast trends through 2034.
Key Takeaways
• Market Size 2024: USD 102.5 Billion
• Forecast for 2034: USD 152.7 Billion
• CAGR (2025-2034): 4.1%
• Top Growth Driver: Biologics and targeted immunomodulatory therapies
• Highest-demand Areas: Rheumatoid arthritis, psoriasis, inflammatory bowel disease (IBD), asthma
• Fastest-growing Region: Asia-Pacific
Market Story
Inflammatory diseases have become a major global healthcare burden, driven by aging populations, lifestyle factors, environmental triggers, and rising autoimmune conditions. Patients are increasingly seeking faster-acting, safer, and more targeted therapies-pushing pharmaceutical companies toward advanced biologics, biosimilars, and precision-based immunomodulators.
Traditional NSAIDs and corticosteroids continue to dominate prescription volumes, but biologic therapies-especially TNF inhibitors, IL inhibitors, and JAK inhibitors-are transforming clinical outcomes for chronic inflammatory diseases such as rheumatoid arthritis, Crohn's disease, ulcerative colitis, and psoriasis.
Growing access to biologics, improved diagnostic capabilities, expansion of specialty clinics, and higher awareness of chronic inflammatory disorders have resulted in increased treatment adoption worldwide.
Explore Full Report here:
https://exactitudeconsultancy.com/reports/49921/anti-inflammatory-therapeutics-market
Market Segments
By Drug Class
• NSAIDs (Largest Volume Contributor)
• Corticosteroids
• Biologics (Strongest Revenue Generator)
• Immunosuppressants
• JAK Inhibitors (Fastest-growing segment)
• Others (COX-2 inhibitors, monoclonal antibodies)
By Indication
• Rheumatoid Arthritis
• Psoriasis & Psoriatic Arthritis
• Inflammatory Bowel Diseases (Crohn's & Ulcerative Colitis)
• Asthma & COPD
• Osteoarthritis
• Allergic Disorders
• Others (Lupus, vasculitis, auto-inflammatory conditions)
By Route of Administration
• Oral
• Injectable (Biologics & JAK inhibitors)
• Topical
• Inhalation (Asthma & respiratory inflammatory disorders)
By End User
• Hospitals
• Specialty Clinics (Immunology, Rheumatology, Dermatology)
• Ambulatory Centers
• Homecare Settings
By Region
• North America: Leads due to strong biologics uptake
• Europe: High prevalence of autoimmune disorders & biosimilar penetration
• Asia-Pacific: Fastest-growing due to rising disease awareness & economic expansion
• South America & Middle East/Africa: Increasing adoption of affordable NSAIDs and biosimilars
Recent Developments
• 2024: Launch of next-generation IL-23 and IL-17 inhibitors for psoriasis with superior response rates.
• 2025: Rapid expansion of JAK inhibitors for rheumatoid arthritis and IBD treatment.
• 2023-2025: Biosimilar uptake increases significantly in Europe and Asia-Pacific, reducing treatment costs.
• 2024: AI-driven inflammatory disease diagnostic tools integrated into clinical workflows.
Get Your Exclusive Offer with up to 10% Discount :
https://exactitudeconsultancy.com/checkout/?currency=USD&type=single_user_license&report_id=49921
Expert Quote
"Anti-inflammatory therapeutics are evolving rapidly, with biologics and targeted immunomodulators offering transformative results for chronic inflammatory diseases. The next decade will bring even more personalized, effective, and safer treatment options,"
- Irfan Tamboli, Business Development Executive, Exactitude Consultancy
Key Market Drivers
• Rising prevalence of chronic inflammatory and autoimmune diseases
• Growing adoption of biologic and targeted therapies
• Advancements in immunology and precision medicine
• Increase in specialty clinics and advanced treatment centers
• Higher awareness of chronic inflammatory disorders
• Expansion of biosimilars improving affordability in developing markets
Forecast & Future Outlook
The Anti-Inflammatory Therapeutics Market will surpass USD 152 billion by 2034, supported by:
• Continued transition from broad-spectrum corticosteroids to targeted biologics
• Growth of next-gen JAK and TYK2 inhibitors
• Higher investment in inflammatory disease R&D
• Improved global access to biosimilars
• Integration of precision diagnostics and personalized treatment plans
Emerging innovations-such as gene therapy, microbiome-modulating drugs, and AI-driven immune profiling-will redefine treatment approaches in the coming decade.
Conclusion
The Anti-Inflammatory Therapeutics Market is positioned for strong long-term growth driven by rising disease burden, expanding treatment options, and rapid technological advancements. As biologics and targeted therapies reshape patient outcomes, global demand for advanced anti-inflammatory solutions will continue to accelerate.
This report is also available in the following languages : Japanese (抗炎症治療薬市場), Korean (항염 치료제 시장), Chinese (抗炎治疗市场), French (Marché des traitements anti-inflammatoires), German (Markt für entzündungshemmende Therapeutika), and Italian (Mercato delle terapie antinfiammatorie), etc.
Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @
https://exactitudeconsultancy.com/request-sample/49921
Our More Reports:
Peripheral Neuropathy Market
https://exactitudeconsultancy.com/reports/49859/peripheral-neuropathy-market
Helicobacter Pylori Test Market
https://exactitudeconsultancy.com/reports/49861/helicobacter-pylori-test-market
Seborrheic Dermatitis Treatment Market
https://exactitudeconsultancy.com/reports/49863/seborrheic-dermatitis-treatment-market
Hba1C Testing Market
https://exactitudeconsultancy.com/reports/49865/hba1c-testing-market
About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
https://bulletin.exactitudeconsultancy.com/
https://www.thehealthanalytics.com/
https://www.analytica.global/
https://www.marketintelligencedata.com/
https://www.marketinsightsreports.com/
https://exactitudeconsultancy.com/
Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Anti-Inflammatory Therapeutics Market to Reach USD 152.7 Billion by 2034 here
News-ID: 4268411 • Views: …
More Releases from Exactitude Consultancy
Medical Simulation Market is expected to reach around USD 6.4 billion by 2034
The global medical simulation market is estimated at approximately USD 2.9 billion in 2024, and is projected to reach around USD 6.4 billion by 2034, representing a compound annual growth rate (CAGR) of about 8.4% during the forecast period from 2025 to 2034. The largest share comes from North America (≈ 40% of revenue in 2024). The fastest-growing region is Asia-Pacific, with projected CAGR ~9% over the forecast period. The…
Smart Healthcare Market is predicted to reach over USD 600 billion by 2034
The smart healthcare market was estimated at approximately USD 200 billion in 2024, and is projected to reach around USD 600 billion by 2034, growing at a compound annual growth rate (CAGR) of 11% over the 2025-2034 period. North America holds the largest share of the market (about 42% in 2024) due to its advanced infrastructure and high technology adoption.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/50093
Market Segmentation…
Antidepressant Drugs Market to Reach USD 23.4 Billion by 2034
Increasing global depression prevalence, expanding telepsychiatry services, and the introduction of fast-acting antidepressants propel strong market growth across regions.
Download Full PDF Sample Copy of Market Report @
https://exactitudeconsultancy.com/request-sample/49919
Introduction
The global Antidepressant Drugs Market is experiencing robust expansion as awareness, diagnosis rates, and acceptance of mental health treatments climb worldwide. With major depressive disorder (MDD), anxiety disorders, and mood-related conditions rising across populations, the need for safe, effective, and fast-acting antidepressants has…
Breast Pumps Market is predicted to increase to over USD 2.9 billion by 2034
The global breast pumps market is valued at approximately USD 1.5 billion in 2024 and is projected to grow to about USD 2.9 billion by 2034, representing a CAGR of 7.2% from 2025 to 2034. North America currently dominates the market (~40% share) and the largest portion of demand is for electric breast pumps. Meanwhile, the Asia-Pacific region is identified as the fastest-growing market, led by increasing working-mother populations, growing…
More Releases for Inflammatory
Inflammatory Myositis Market Massive Growth opportunity Ahead
Introduction
Inflammatory myositis is a group of rare autoimmune disorders characterized by chronic inflammation of skeletal muscles, leading to progressive muscle weakness, fatigue, and functional disability. The spectrum includes polymyositis (PM), dermatomyositis (DM), inclusion body myositis (IBM), immune-mediated necrotizing myopathy (IMNM), and overlap syndromes. These disorders can also involve other organs, most notably the lungs (interstitial lung disease), skin, heart, and joints, complicating disease management.
Historically, corticosteroids and conventional immunosuppressants have formed…
Rising Incidence Of Inflammatory Bowel Disease Fuels Growth In The Anti-Inflamma …
The Anti-Inflammatory Therapeutics Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Anti-Inflammatory Therapeutics Market Size and Projected Growth Rate?
The market size of anti-inflammatory therapeutics has shown a consistent growth in the past few years. The market is projected to expand from $114.71…
Rising Incidence Of Inflammatory Bowel Disease Fuels Growth In The Anti-Inflamma …
What market dynamics are playing a key role in accelerating the growth of the anti-inflammatory therapeutics market?
As inflammatory bowel disease becomes more commonplace, it is predicted to encourage progress in the anti-inflammatory therapeutics market. Characterized as a long-term condition causing inflammation of the digestive tract, inflammatory bowel disease (IBD) is effectively managed with the usage of anti-inflammatory therapeutics. These treatments are central in the control of Crohn's disease via decreasing…
Anti-Inflammatory Activity Enzyme Manufacturer | Pearlzyme Inc
Pearlzyme Inc. is a South Korean company that manufactures anti inflammatory activity enzymes. This anti-inflammatory activity enzyme boosts the animal's immune system against infection and increases milk lactation.
Pearlzyme Inc. is committed to providing high-quality products and services to its customers. The company has a team of experienced scientists and engineers who are constantly working to develop new and innovative products. Pearlzyme Inc. is also committed to sustainable development and is…
Inflammatory Bowel Disease Market: The Present and Future of Inflammatory Bowel …
Stratagem Market Insights have included the latest addition of a global market research report titled Inflammatory Bowel Disease Market tits expansive repository. The report studies primary and secondary research in order to analyze the data effectively. The market study further draws attention to crucial industry factors such as global clients, potential customers, and sellers, which instigates positive company growth. In order to gauge the turning point of the businesses, significant…
Rising incidences of chronic inflammatory and autoimmune diseases has increased …
According to a new report published by apacmarket.com, titled, Anti-inflammatory Therapeutics Asia-Pacific Market Research Report, 2014-2020, the Asia-Pacific anti-inflammatory therapeutics market is expected to grow at a CAGR of 8.6% during the period of 2015-2020. The arthritis segment would continue to lead the Asia Pacific anti-inflammatory therapeutics market through 2020. China anti-inflammatory therapeutics market is forecast to grow at the highest CAGR of 13.9% during the forecast period.
Get the sample…
